Nimbus Therapeutics Reaches Summit In Deal With Celgene

Nimbus and Celgene announced a significant partnership focused on autoimmune and inflammatory diseases. Here are the three unique elements of the Nimbus model.

Source: Forbes.com Healthcare News - October 3, 2017 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Tags: NASDAQ:CELG Source Type: news